Targeting a disintegrin and metalloprotease (ADAM) 17-CD122 axis enhances CD8+ T cell effector differentiation and anti-tumor immunity.

Details

Language :

English

ISSN :

20959907

Volume :

9

Issue :

1

Database :

Complementary Index

Journal :

Signal Transduction & Targeted Therapy

Publication Type :

Academic Journal

Accession number :

178086778

Full Text :

https://doi.org/10.1038/s41392-024-01873-6